Laurent D. Hermouet
With over 20 years of fixed-income experience, Mr. Laurent Hermouet, CFA specializes in providing credit to small and medium-sized, fast-growing companies. As one of the three original partners of Athyrium Capital Management and a member of its investment committee, Mr. Hermouet has deployed over $1.5 bn of capital in biopharma, medical devices, and pharma services companies. Mr. Hermouet partners with management teams and board members in the US and Europe to craft bespoke capital structure solutions for companies reaching key growth inflection points. Prior to Athyrium, Mr. Hermouet was a senior credit analyst at Citigroup Alternative Investments and a credit analyst at Goldman, Sachs & Co. He has been a CFA Charterholder and a member of the New York Society of Security Analysts since 2001.
Wednesday March 6, 2024
A Healthy Alternative: Venture Debt Financing for Healthcare Industries
- Venture debt financing options for health and tech companies
- Non-dilutive financing solutions for healthcare
- Specific concerns related to the health and tech industries